Efficacy and tolerability of combination of carfilzomib, lenalidomide and dexamethasone in relapsed/refractory Multiple Myeloma patients in real life
Latest Information Update: 24 Jul 2017
At a glance
- Drugs Carfilzomib (Primary) ; Lenalidomide (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 24 Jul 2017 New trial record
- 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association